Latest News and Press Releases

Want to stay updated on the latest news?

Sign into Reader Account Create Reader Account

February 17, 2016 08:47 ET | Source: Alcobra Ltd.

CORRECTING and REPLACING -- Alcobra Announces Fourth Quarter and Fiscal 2015 Financial Results and Provides Corporate Update

Conference Call & Webcast February 17th at 8:30 a.m. Eastern Time/5:30 a.m. Pacific Time TEL AVIV, Israel, Feb. 17, 2016 (GLOBE NEWSWIRE) -- In a release issued under the same headline...
February 17, 2016 08:00 ET | Source: Alcobra Ltd.

Alcobra Announces Fourth Quarter and Fiscal 2015 Financial Results and Provides Corporate Update

Conference Call & Webcast February 17th at 8:30 a.m. Eastern Time/5:30 a.m. Pacific Time TEL AVIV, Israel, Feb. 17, 2016 (GLOBE NEWSWIRE) -- Alcobra Ltd. (Nasdaq:ADHD), an emerging...
February 02, 2016 08:00 ET | Source: Alcobra Ltd.

Alcobra Ltd. to Release Fourth Quarter and Fiscal Year 2015 Financial Results and Host Corporate Update Conference Call & Webcast on February 17

TEL AVIV, Israel, Feb. 02, 2016 (GLOBE NEWSWIRE) -- Alcobra Ltd. (Nasdaq:ADHD), an emerging pharmaceutical company focused on the development of new medications to help patients with cognitive...
January 28, 2016 08:00 ET | Source: Alcobra Ltd.

Alcobra Ltd. to Present at Upcoming Investment Conferences

TEL AVIV, Israel, Jan. 28, 2016 (GLOBE NEWSWIRE) -- Alcobra Ltd. (Nasdaq:ADHD), an emerging pharmaceutical company focused on the development of new medications to help patients with cognitive...
December 17, 2015 08:00 ET | Source: Alcobra Ltd.

Alcobra Added to the NASDAQ Biotechnology Index

TEL AVIV, Israel, Dec. 17, 2015 (GLOBE NEWSWIRE) -- Alcobra Ltd. (Nasdaq:ADHD), an emerging pharmaceutical company focused on the development of new medications to help patients with cognitive...
November 24, 2015 08:00 ET | Source: Alcobra Ltd.

Alcobra Ltd. to Participate in Piper Jaffray 27th Annual Healthcare Conference

TEL AVIV, Israel, Nov. 24, 2015 (GLOBE NEWSWIRE) -- Alcobra Ltd. (Nasdaq:ADHD), an emerging pharmaceutical company focused on the development of new medications to help patients with cognitive...
November 16, 2015 08:00 ET | Source: Alcobra Ltd.

Alcobra Ltd. to Present at Upcoming Investment Conferences Company Will Host Corporate Update Conference Call & Webcast on November 17

TEL AVIV, Israel, Nov. 16, 2015 (GLOBE NEWSWIRE) -- Alcobra Ltd. (Nasdaq:ADHD), an emerging pharmaceutical company focused on the development of new medications to help patients with cognitive...
November 13, 2015 08:45 ET | Source: Alcobra Ltd.

Alcobra Ltd. Prices Public Offering of Ordinary Shares

TEL AVIV, Israel, Nov. 13, 2015 (GLOBE NEWSWIRE) -- Alcobra Ltd. (Nasdaq:ADHD) announced the pricing of its previously announced underwritten public offering of 6,175,000 ordinary shares at an...
November 12, 2015 16:05 ET | Source: Alcobra Ltd.

Alcobra Ltd. Announces Proposed Public Offering of Ordinary Shares

TEL AVIV, Israel, Nov. 12, 2015 (GLOBE NEWSWIRE) -- Alcobra Ltd. (Nasdaq:ADHD) announced today that it intends to offer its ordinary shares in an underwritten public offering. Jefferies LLC and...
November 12, 2015 16:01 ET | Source: Alcobra Ltd.

Alcobra Announces Third Quarter 2015 Financial Results and Provides Corporate Update

Conference Call & Webcast November 17th at 8:30 a.m. Eastern Time/5:30 a.m. Pacific Time The company provides an update on its Fragile X Syndrome development program TEL AVIV, Israel,...

keyboard_arrow_left Previous Page

Next Page keyboard_arrow_right